Annual Drug Patent Expirations for GLUMETZA
Glumetza is a drug marketed by Santarus Inc and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for GLUMETZA.
This drug has thirty-four patent family members in fifteen countries.
The generic ingredient in GLUMETZA is metformin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
